UnknownNot Applicable

Biomarkers and Prediction of Tigecycline Induced Coagulation Dysfunction

200 participantsStarted 2023-05-01

Plain-language summary

This study is to screen out the biomarkers and establish the model to predict coagulation dysfunction induced tigecycline

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Inpatients receiving tigecycline treatment in the Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School * Intravenous tigecycline ≥ 3 days * Monitoring the plasma concentration of tigecycline Exclusion Criteria: * Missing clinical data

What they're measuring

Biomarkers associated with the coagulation dysfunction induced tigecycline

Timeframe: January 2023-December 2025

Trial details

NCT IDNCT05698160

SponsorThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-12-31

View on ClinicalTrials.gov More Blood Coagulation Disorder trials